Cambridge Investment Research Advisors
KYMR icon

Cambridge Investment Research Advisors’s Kymera Therapeutics KYMR Stock Holding History

Cambridge Investment Research Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$745K Sell
6,495
-32
-0.5% -$2.75K ﹤0.01% 2574
2026
Q1 		$544K Buy
6,527
+29
+0.4% +$2.3K ﹤0.01% 2720
2025
Q4 		$506K Sell
6,498
-2,576
-28% -$174K ﹤0.01% 2709
2025
Q3 		$514K Buy
9,074
+49
+0.5% +$2.21K ﹤0.01% 2654
2025
Q2 		$394K Buy
9,025
+11
+0.1% +$379 ﹤0.01% 2763
2025
Q1 		$247K Hold
9,014
– – ﹤0.01% 3039
2024
Q4 		$363K Hold
9,014
– – ﹤0.01% 2681
2024
Q3 		$427K Sell
9,014
-1,000
-10% -$44.2K ﹤0.01% 2534
2024
Q2 		$299K Hold
10,014
– – ﹤0.01% 2705
2024
Q1 		$403K Buy
10,014
+1,000
+11% +$35.8K ﹤0.01% 2463
2023
Q4 		$229K Buy
+9,014
New +$161K ﹤0.01% 2811
2023
Q3 		– Sell
-9,014
Closed -$207K – 3211
2023
Q2 		$207K Hold
9,014
– – ﹤0.01% 2844
2023
Q1 		$267K Hold
9,014
– – ﹤0.01% 2589
2022
Q4 		$225K Buy
+9,014
New +$240K ﹤0.01% 2657
2022
Q2 		– Sell
-9,014
Closed -$381K – 3149
2022
Q1 		$381K Hold
9,014
– – ﹤0.01% 2342
2021
Q4 		$572K Hold
9,014
– – ﹤0.01% 1994
2021
Q3 		$529K Sell
9,014
-100
-1% -$5.8K ﹤0.01% 2008
2021
Q2 		$442K Buy
9,114
+100
+1% +$4.34K ﹤0.01% 2147
2021
Q1 		$350K Hold
9,014
– – ﹤0.01% 2177
2020
Q4 		$559K Buy
+9,014
New +$440K ﹤0.01% 1699

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Cambridge Investment Research Advisors's KYMR Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Kymera Therapeutics (KYMR) stake by 0.49% in Q2 2026, selling an estimated $2.75K and leaving 6,495 shares worth $745K. The position accounts for ﹤0.01% of the portfolio, ranked #2574.

Cambridge Investment Research Advisors first reported a position in KYMR in Q4 2020 and has held it in 20 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Cambridge Investment Research Advisors held 6,495 shares of Kymera Therapeutics worth $745K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 32 Kymera Therapeutics shares in Q2 2026, an estimated $2.75K.
  • Kymera Therapeutics made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2574 holding.
  • Cambridge Investment Research Advisors first reported a position in Kymera Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.